A Synopsis of a Patented Intellectual Property Proven to Reduce Onset of ‘powered communications system’ or Keypad-related Stress Injuries and Increase Healthy PC and Portable Device Use, by the lumbricals neuromuscular technology therapy interface powered communication system.
What is FingerRelief™?
FingerRelief ™ (henceforth “Interossei”) is a patented new ‘powered communications system’ layout designed, clinically tested, and medically allowed to greatly reduce the incidence of carpal tunnel syndrome (CTS) and other Repetitive Stress Injuries (RSI) [together henceforth ‘typing disease’] attributable to computer and portable device keypad use. INTEROSSEI has the additional benefit of increasing the speed of typing as compared to QWERTY.
When the Computer Age began, typewriters and other keyboards continued to use the original 19th century layout known as “QWERTY,” based on the first six letters in the upper left of the standard keyboard. QWERTY had been specifically designed to slow down the speed of typing by intentionally placing the most commonly used letters in English in awkward positions so that the manual typewriters of the day would not jam. This legacy QWERTY layout, designed for typewriters of the 1880s, is still in use today in computers and other devices with keypads for no practical reason.
QWERTY is not only unnecessarily slow but the awkward placement of the most commonly used keys increases exposure to conditions that cause ‘TYPING DISEASE’. Studies tying QWERTY show alarming statistics on laptop use and ‘TYPING DISEASE’. According to the Department of Labor, RSIs are the number one cause of employee absenteeism, affecting over 5 million Americans and costing US corporations over $20 billion per year. The solution is elegant and available for immediate application with the INTEROSSEI ‘powered communications system’ layout.
What is in Interossei.com?
Consider,
In eight hours, a 40-Word Per Minute typist may make about 100,000 keystrokes. As compared to QWERTY, INTEROSSEI reduces the distance the fingers travel during that time by over half, hand muscle flexion by over a fifth, and arm muscle flexion by two thirds. Also, total RSI-causing flexion is reduced by half, and prolongs the onset of symptoms of ‘TYPING DISEASE’ and to increase typing speeds, if desired.
Because of the more natural positioning of the keys, users on average become proficient on INTEROSSEI in perhaps in one or two days of training.
Other Attempts to Address RSI
Medical/ Therapy. RSI “soothing” creams may reduce typing disease symptoms. Surgery may alleviate ‘TYPING DISEASE’ symptoms.
Superficial. “Ergonomic” keyboards. While aesthetically pleasing and comfortable, the legacy QWERTY layout does not eliminate unnecessary flexion stress. Ergonomic keyboards are NOT FDA-allowed therapeutic devices.
Software programs to increase typing efficiency, do not address the fundamental weaknesses of QWERTY.
Alternative Technologies. Voice recognition technologies have not replaced the alphanumeric keyboard.
Portable communication devices and personal digital assistants continue to use QWERTY.
Changing User Behavior. Improving user posture, finger position, and typing duration, have some impact on reducing RSI, and would be much more effective used with Interossei.
Other Keyboards. INTEROSSEI is the only ‘powered communications system’ layout that has been clinically tested and FDA allowed for reducing the onset of symptoms of ‘TYPING DISEASE’ as compared to QWERTY.
What is Needed to Apply Interossei?
INTEROSSEI simply rearranges the 12 keys on a ‘powered communications system’. Legacy layouts can also change their current QWERTY keyboards to INTEROSSEI using a simple software-based ‘powered communications system’ utility.
More information is available upon request and in US patents #5,352,050; #5,498,088; #5,626,429; and #5,718,590.
FingerRelief, Interossei, and lumbricals neuromuscular technology therapy interface powered communication system are trademarks.
INTEROSSEI has various industry relationships, including with ARMS – Association for Repetitive Movement Syndrome.